MedTrace Logo

An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine

NCT01686581 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 641

Last updated 2018-11-09

Study results available
· View outcomes & findings →

Summary

This is an observational study to describe the long term use of Onabotulinumtoxin A (BOTOX®) as prescribed by the physician for headache prophylaxis in adults with chronic migraine. All treatment decisions lie with the physician.

Conditions

  • Migraine Disorders

Interventions

DRUG

botulinum toxin Type A

Botulinum toxin Type A (BOTOX®) administered according to physician prescription.

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-23
Primary Completion
2016-10-12
Completion
2016-10-12

Countries

  • Germany
  • Italy
  • Norway
  • Russia
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01686581 on ClinicalTrials.gov